S-1 (TS-1) maintained complete response for approximately 10 years in a case of metastatic breast cancer.

Breast cancer (Tokyo, Japan)

Volumn 13, Issue 2, 2006, Pages 220-224

  Taira, Naruto ^a   Aogi, Kenjiro ^a   Ohsumi, Shozo ^a   Takashima, Shigemitsu ^a   Nishimura, Rieko ^a   Doihara, Hiroyoshi ^a   Saeki, Toshiaki ^a  

^a NATIONAL HOSPITAL ORGANIZATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1-HEXYLCARBAMOYL-5-FLUOROURACIL; ANTINEOPLASTIC AGENT; CARMOFUR; DRUG DERIVATIVE; FLUOROURACIL; TAMOXIFEN; TEGAFUR;

ADJUVANT CHEMOTHERAPY; ARTICLE; BREAST TUMOR; CANCER STAGING; CASE REPORT; DOSE RESPONSE; DRUG ADMINISTRATION; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG TUMOR; MASTECTOMY; METASTASIS; MIDDLE AGED; NEEDLE BIOPSY; ORAL DRUG ADMINISTRATION; PAGET NIPPLE DISEASE; PATHOLOGY; REMISSION; RISK ASSESSMENT; TIME; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY, NEEDLE; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CHEMOTHERAPY, ADJUVANT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MASTECTOMY, MODIFIED RADICAL; MIDDLE AGED; NEOPLASM STAGING; REMISSION INDUCTION; RISK ASSESSMENT; TAMOXIFEN; TEGAFUR; TIME FACTORS; TREATMENT OUTCOME;

EID: 33746857783     PISSN: 13406868     EISSN: None     Source Type: Journal    
DOI: 10.2325/jbcs.13.220     Document Type: Article

References (0)